- Abstract
- Core Tip
- Article Highlights
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (4)
- Timeline of Article Publication (0)
- Authors Evaluation (1)
- Article Quality Tracking (0)
- Reference Citation Analysis (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4581)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 9, 2023 (publication date) through May 7, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Pediatrics
ISSN
2219-2808
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Maitra P, Prema S, Narendran V, Shah PK. Safety and efficacy of intravitreal anti vascular endothelial growth factor for severe posterior retinopathy of prematurity with flat fibrovascular proliferation. World J Clin Pediatr 2023; 12(4): 220-229 [PMID: 37753496 DOI: 10.5409/wjcp.v12.i4.220] |
|---|---|
| URL: | https://www.wjgnet.com/2219-2808/full/v12/i4/220.htm |
| Number | Citing Articles |
| 1 |
Puja Maitra, Sujay Jaju, Kushal U. Agrawal, Abhishek Das, Prema Subramaniam, Narendran Venkatapathy, Parag K. Shah. Comparing safety and efficacy of Bevacizumab, Ranibizumab and Ranibizumab biosimilar in Retinopathy of prematurity. Eye 2025; doi: 10.1038/s41433-025-03735-z
|
| 2 |
梦玲 何. Adverse Effects and Management Strategies of Anti-VEGF Therapy for Retinopathy of Prematurity. Advances in Clinical Medicine 2025; 15(04): 2566 doi: 10.12677/acm.2025.1541214
|